Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology source : Www.allogene.com save search
8-K: Report of unscheduled material events or corporate event
Published: 2023-06-07 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.17%
H: 0.69%
C: -0.51%
report
8-K: Report of unscheduled material events or corporate event
Published: 2023-05-03 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.35%
H: 20.53%
C: 13.16%
report
10-Q: Quarterly report which provides a continuing view of a company's financial position
Published: 2023-05-03 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.35%
H: 20.53%
C: 13.16%
report financial
3: Initial filing by director officer or owner of more than ten percent.
Published: 2023-04-26 (Crawled : 22:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 1.29%
H: 1.82%
C: -3.27%
4: Statement of changes in beneficial ownership of securities
Published: 2023-04-26 (Crawled : 22:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 1.29%
H: 1.82%
C: -3.27%
Allogene Therapeutics to Report First Quarter 2023 Financial Results on May 3, 2023
Published: 2023-04-25 (Crawled : 13:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
report therapeutics financial results
DEFA14A: Additional proxy soliciting materials – definitive
Published: 2023-04-24 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
defa14
DEF 14A: Official notification to shareholders of matters to be brought to a vote (“Proxy”)
Published: 2023-04-24 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
ARS: An annual report to security holders
Published: 2023-04-24 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
report security
Allogene Therapeutics Appoints Timothy Moore as Chief Technical Officer
Published: 2023-04-20 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.8%
H: 10.81%
C: 9.29%
therapeutics moore
8-K: Report of unscheduled material events or corporate event
Published: 2023-04-20 (Crawled : 21:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.8%
H: 10.81%
C: 9.29%
report
Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
Published: 2023-04-13 (Crawled : 13:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 1.31%
H: 12.04%
C: 8.6%
therapeutics
3: Initial filing by director officer or owner of more than ten percent.
Published: 2023-04-05 (Crawled : 23:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.61%
C: -1.01%
4: Statement of changes in beneficial ownership of securities
Published: 2023-04-05 (Crawled : 23:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.61%
C: -1.01%
Allogene Therapeutics Publishes 2022 Annual Environmental, Social and Governance (ESG) Report
Published: 2023-03-30 (Crawled : 13:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 0.78%
H: 1.55%
C: -3.5%
report therapeutics
4: Statement of changes in beneficial ownership of securities
Published: 2023-03-25 (Crawled : 04:20) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
| Email alert
Add to watchlist
4: Statement of changes in beneficial ownership of securities
Published: 2023-03-16 (Crawled : 22:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.91%
H: 1.83%
C: 0.55%
8-K: Report of unscheduled material events or corporate event
Published: 2023-03-10 (Crawled : 22:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
| Email alert
Add to watchlist
report
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
Published: 2023-03-02 (Crawled : 14:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: -0.79%
H: 2.7%
C: -4.29%
therapeutics
Allogene Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Published: 2023-02-28 (Crawled : 22:00) - allogene.com
ALLO | $3.04 -9.79% -10.86% 2.1M
|
Health Technology
|
| O: 6.14%
H: 5.93%
C: -5.93%
year therapeutics financial update results
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.